Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00098605 | Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Jun 6, 2013 | clinicaltrials |
| NCT00055861 | Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer | completed | Phase 2 | 27 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00003992 | Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2 | completed | Phase 2 | 200 | National Cancer Institute (NCI)NIH | 2 | Jun 3, 2013 | clinicaltrials |
| NCT00003205 | Bryostatin 1 in Treating Patients With Stage IV Breast Cancer | completed | Phase 2 | — | University of Colorado, DenverOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00003752 | Bexarotene in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 180 | Ligand PharmaceuticalsINDUSTRY | 1 | May 30, 2013 | clinicaltrials |
| NCT00004900 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | — | Hackensack Meridian HealthOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00004906 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | — | Hackensack Meridian HealthOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00044993 | Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer | completed | Phase 2 | — | Introgen TherapeuticsINDUSTRY | 1 | May 30, 2013 | clinicaltrials |
| NCT00074100 | Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00558272 | Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease | completed | Phase 2 | 139 | AstraZenecaINDUSTRY | 8 | May 27, 2013 | clinicaltrials |
| NCT00662025 | Study Of Sunitinib With Capecitabine In Breast Cancer | completed | Phase 2 | 63 | PfizerINDUSTRY | 1 | May 27, 2013 | clinicaltrials |
| NCT01856452 | Comparison Study of Sentinel Lymph Node Biopsy by Multimodal Method in Breast Cancer | completed | Phase 2 | 86 | National Cancer Center, KoreaOTHER_GOV | 1 | May 17, 2013 | clinicaltrials |
| NCT00060138 | Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases | completed | Phase 1 / Phase 2 | — | Chugai PharmaceuticalINDUSTRY | 1 | May 15, 2013 | clinicaltrials |
| NCT00117442 | A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood | completed | Phase 2 | 61 | AmgenINDUSTRY | 0 | May 13, 2013 | clinicaltrials |
| NCT00670982 | Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer | completed | Phase 2 | 29 | Harold J. Burstein, MD, PhDOTHER | 1 | May 13, 2013 | clinicaltrials |
| NCT01433562 | Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer Patients | completed | Phase 2 / Phase 3 | 40 | Dexa Medica GroupINDUSTRY | 1 | May 13, 2013 | clinicaltrials |
| NCT00077857 | A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 2 | 470 | Hoffmann-La RocheINDUSTRY | 9 | May 10, 2013 | clinicaltrials |
| NCT00060255 | High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors | completed | Phase 2 | 451 | Roswell Park Cancer InstituteOTHER | 1 | May 9, 2013 | clinicaltrials |
| NCT00006370 | Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer | completed | Phase 2 | 275 | Novartis PharmaceuticalsINDUSTRY | 1 | May 1, 2013 | clinicaltrials |
| NCT00003425 | Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect | completed | Phase 1 / Phase 2 | 25 | University of KentuckyOTHER | 1 | Apr 26, 2013 | clinicaltrials |
| NCT00097721 | A Study of E7389 in Advanced/Metastatic Breast Cancer Patients | completed | Phase 2 | 104 | Eisai Inc.INDUSTRY | 1 | Apr 22, 2013 | clinicaltrials |
| NCT01216033 | Exploratory Study of Breast Cancer With ABY025(ABY0125) | completed | Phase 1 / Phase 2 | 7 | Biomedical Radiation SciencesOTHER | 1 | Apr 15, 2013 | clinicaltrials |
| NCT00033384 | CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 2 | — | University of Alabama at BirminghamOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00429182 | Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer | completed | Phase 2 | 32 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00148668 | Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer | completed | Phase 2 | 81 | Eric Winer, MDOTHER | 1 | Apr 9, 2013 | clinicaltrials |
| NCT00509769 | A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) Administered Intravenously to Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer | completed | Phase 2 | 112 | Genentech, Inc.INDUSTRY | 1 | Apr 2, 2013 | clinicaltrials |
| NCT00003408 | Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer | completed | Phase 2 | 40 | Cancer Treatment Centers of AmericaOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00005908 | Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 1 | Mar 19, 2013 | clinicaltrials |
| NCT00244959 | Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer | completed | Phase 2 | 54 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 19, 2013 | clinicaltrials |
| NCT00072319 | Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 4, 2013 | clinicaltrials |
| NCT00107016 | Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women | completed | Phase 2 | 267 | Novartis PharmaceuticalsINDUSTRY | 10 | Mar 4, 2013 | clinicaltrials |
| NCT00122369 | Self Hypnotic Relaxation As An Adjunct To Local Anesthesia During Large Core Breast Biopsy | completed | Phase 2 | 240 | Beth Israel Deaconess Medical CenterOTHER | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00767520 | Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast Cancer | completed | Phase 2 | 155 | Bristol-Myers SquibbINDUSTRY | 8 | Feb 28, 2013 | clinicaltrials |
| NCT00077363 | Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer | completed | Phase 2 | 70 | National Cancer Institute (NCI)NIH | 1 | Feb 27, 2013 | clinicaltrials |
| NCT00811824 | Effects of Physical Activity and Dietary Change in Minority Breast Cancer Survivors | completed | Phase 2 | 42 | Columbia UniversityOTHER | 1 | Feb 22, 2013 | clinicaltrials |
| NCT00049062 | Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer | completed | Phase 2 | — | The University of Texas Health Science Center at San AntonioOTHER | 1 | Feb 21, 2013 | clinicaltrials |
| NCT00136539 | Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer | completed | Phase 2 | 41 | Harold J. Burstein, MD, PhDOTHER | 1 | Feb 18, 2013 | clinicaltrials |
| NCT00003796 | Irofulven in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 32 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00962494 | Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors | completed | Phase 2 | 585 | Stanford UniversityOTHER | 2 | Feb 7, 2013 | clinicaltrials |
| NCT01784393 | Chemoradiation for Bone Metastasis | completed | Phase 2 | 29 | Rabin Medical CenterOTHER | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00558103 | Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer | completed | Phase 2 | 163 | GlaxoSmithKlineINDUSTRY | 28 | Feb 4, 2013 | clinicaltrials |
| NCT00005817 | Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer | completed | Phase 2 | 42 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00050141 | Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer | completed | Phase 2 | 121 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 6 | Feb 1, 2013 | clinicaltrials |
| NCT00534417 | Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer | completed | Phase 2 | 41 | Accelerated Community Oncology Research NetworkOTHER | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00003041 | Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer | completed | Phase 2 | — | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00003068 | High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer | completed | Phase 2 | 30 | University of ArizonaOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00319254 | Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer | completed | Phase 2 | 75 | PfizerINDUSTRY | 8 | Jan 31, 2013 | clinicaltrials |
| NCT00645177 | Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast Cancer | completed | Phase 2 | 10 | AbbVie (prior sponsor, Abbott)INDUSTRY | 2 | Jan 29, 2013 | clinicaltrials |
| NCT00003953 | Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer | completed | Phase 2 | 39 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 28, 2013 | clinicaltrials |
Data updated 24 days agoSource updated Jun 6, 2013source: clinicaltrials